TALIS BIOMEDICAL CORP (TLIS) Forecast, Price Target & Analyst Ratings

NASDAQ:TLIS • US87424L2079

Current stock price

4.38 USD
+0.22 (+5.29%)
At close:
4.49 USD
+0.11 (+2.51%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TALIS BIOMEDICAL CORP (TLIS).

Forecast Snapshot

Consensus Price Target

Price Target
$5.10
+ 16.44% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 12, 2024
Period
Q3 / 2024
EPS Estimate
-$5.16
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
36.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.10
Upside
+ 16.44%
From current price of $4.38 to mean target of $5.10, Based on 6 analyst forecasts
Low
$5.05
Median
$5.10
High
$5.25

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for TLIS. The average price target is 5.1 USD. This implies a price increase of 16.44% is expected in the next year compared to the current price of 4.38.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TLIS Current Analyst RatingTLIS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

TLIS Historical Analyst RatingsTLIS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
36.67%
TLIS was analyzed by 6 analysts. The buy percentage consensus is at 37. So analysts seem to be rather negative about TLIS.
In the previous month the buy percentage consensus was at a similar level.
TLIS was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-08-16BTIGMaintains Sell -> Sell
2022-01-07B of A SecuritiesDowngrade Neutral -> Underperform
2021-09-27JP MorganDowngrade Neutral -> Underweight
2021-08-12Piper SandlerDowngrade Overweight -> Neutral
2021-08-11JP MorganDowngrade Overweight -> Neutral
2021-03-09BTIGInitiate Buy
2021-03-09JP MorganInitiate Overweight
2021-03-09B of A SecuritiesInitiate Neutral
2021-03-09Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 12, 2024
Period
Q3 / 2024
EPS Estimate
-$5.16
Revenue Estimate
Revenue Q2Q
-100.00%
EPS Q2Q
40.13%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

TLIS is expected to report earnings on 11/12/2024. The consensus EPS estimate for the next earnings is -5.16 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025
Revenue
YoY % growth
TLIS revenue by date.TLIS revenue by date.
8.193M
-25.10%		4.812M
-41.27%		2.134M
-55.65%
-100.00%		13.26M
EBITDA
YoY % growth
TLIS ebitda by date.TLIS ebitda by date.
-190.238M
-110.39%		-106.309M
44.12%		-63.245M
40.51%		-80.58M
-27.41%		-68.34M
15.19%
EBIT
YoY % growth
TLIS ebit by date.TLIS ebit by date.
-191.816M
-110.36%		-115.139M
39.97%		-64.015M
44.40%		-72.42M
-13.13%		-70.125M
3.17%
Operating Margin
TLIS operating margin by date.TLIS operating margin by date.
-2,341.22%-2,392.75%-2,999.77%N/A-528.85%
EPS
YoY % growth
TLIS eps by date.TLIS eps by date.
-27.51
73.20%		-63.60
-131.19%		N/A
48.33%		-23.79
27.62%		-28.34
-19.13%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-5.16
40.13%		-5.91
13.32%		-7.13
-6.23%		-7.17
-18.95%		-7.48
-44.86%		-6.56
-11.05%
Revenue
Q2Q % growth
-100.00%
-100.00%
-100.00%		408K12.852M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-10.812M
23.70%		-12.342M
14.62%		-14.79M
-62.22%		-14.892M
-73.61%		-15.504M
-43.40%		-13.872M
-12.40%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TLIS Yearly Revenue VS EstimatesTLIS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2025 2M 4M 6M 8M 10M
TLIS Yearly EPS VS EstimatesTLIS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -50 -100

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

TALIS BIOMEDICAL CORP / TLIS Forecast FAQ

What do analysts expect the price target to be for TALIS BIOMEDICAL CORP (TLIS)?

6 analysts have analysed TLIS and the average price target is 5.1 USD. This implies a price increase of 16.44% is expected in the next year compared to the current price of 4.38.

Can you provide the upcoming earnings date for TALIS BIOMEDICAL CORP?

TALIS BIOMEDICAL CORP (TLIS) will report earnings on 2024-11-12, after the market close.

What are the consensus estimates for TLIS stock next earnings?

The consensus EPS estimate for the next earnings of TALIS BIOMEDICAL CORP (TLIS) is -5.16 USD and the consensus revenue estimate is 0 USD.

Can you provide the consensus rating for TALIS BIOMEDICAL CORP stock?

The consensus rating for TALIS BIOMEDICAL CORP (TLIS) is 36.6667 / 100 . This indicates that analysts generally have a negative outlook on the stock.